Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Epidemiology and outcomes of acute liver failure in Australia.

Hey P, Hanrahan TP, Sinclair M, Testro AG, Angus PW, Peterson A, Warrillow S, Bellomo R, Perini MV, Starkey G, Jones RM, Fink M, McClure T, Gow P.

World J Hepatol. 2019 Jul 27;11(7):586-595. doi: 10.4254/wjh.v11.i7.586.

2.

Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.

Papaluca T, Sinclair M, Gow P, Pianko S, Sievert W, Arachchi N, Cameron K, Bowden S, O'Keefe J, Doyle J, Stoove M, Hellard M, Iser D, Thompson A.

Liver Int. 2019 Jul 29. doi: 10.1111/liv.14201. [Epub ahead of print]

PMID:
31355968
3.

The footwear experiences of people with gout: a qualitative study.

Frecklington M, Williams A, Dalbeth N, McNair P, Gow P, Rome K.

J Foot Ankle Res. 2019 Jul 12;12:38. doi: 10.1186/s13047-019-0349-7. eCollection 2019.

4.

Handgrip strength adds more prognostic value to the MELD score than imaging-based measures of muscle mass in men with cirrhosis.

Sinclair M, Chapman B, Hoermann R, Angus PW, Testro A, Scodellaro T, Gow PJ.

Liver Transpl. 2019 Jul 8. doi: 10.1002/lt.25598. [Epub ahead of print]

PMID:
31282126
5.

Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply.

Grigg SE, Sarri GL, Gow PJ, Yeomans ND.

Aliment Pharmacol Ther. 2019 Jul;50(1):117-120. doi: 10.1111/apt.15324. No abstract available.

PMID:
31184392
6.

Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review and meta-analysis.

Koshy AN, Ha FJ, Gow PJ, Han HC, Amirul-Islam FM, Lim HS, Teh AW, Farouque O.

Heart. 2019 Sep;105(17):1335-1342. doi: 10.1136/heartjnl-2018-314649. Epub 2019 Apr 24.

PMID:
31018953
7.

Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial.

Frecklington M, Dalbeth N, McNair P, Morpeth T, Vandal AC, Gow P, Rome K.

Arthritis Res Ther. 2019 Apr 24;21(1):104. doi: 10.1186/s13075-019-1886-y.

8.

Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

Grigg SE, Sarri GL, Gow PJ, Yeomans ND.

Aliment Pharmacol Ther. 2019 May;49(10):1260-1273. doi: 10.1111/apt.15253. Epub 2019 Apr 15. Review.

PMID:
30989721
9.

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels.

Nicoll AJ, Roberts SK, Lim R, Mitchell J, Weltman M, George J, Wigg A, Stuart K, Gow P, MacQuillan G, Tse E, Levy M, Sood S, Zekry A, Cheng W, Mitchell J, Skoien R, Sievert W, Strasser SI, McCaughan GW; ALA Clinical Research Network, Gastroenterological Society of Australia.

Aliment Pharmacol Ther. 2019 May;49(10):1314-1322. doi: 10.1111/apt.15248. Epub 2019 Apr 11.

PMID:
30972807
10.

Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.

Sinclair M, Hoermann R, Peterson A, Testro A, Angus PW, Hey P, Chapman B, Gow PJ.

Liver Int. 2019 Jun;39(6):1089-1097. doi: 10.1111/liv.14071. Epub 2019 Feb 25.

PMID:
30746903
11.

Thermal approach to classifying sequentially written fiber Bragg gratings.

Scholl SL, Jantzen A, Bannerman RHS, Gow PC, Smith DH, Gates JC, Boyd LJ, Smith PGR, Holmes C.

Opt Lett. 2019 Feb 1;44(3):703-706. doi: 10.1364/OL.44.000703.

PMID:
30702715
12.

Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation.

Vasudevan A, Ardalan ZS, Ahmed N, Apostolov R, Gow PJ, Testro AG, Gane EJ, Angus PW.

JGH Open. 2018 Sep 19;2(6):288-294. doi: 10.1002/jgh3.12086. eCollection 2018 Dec.

13.

Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant.

Kutaiba N, Ardalan Z, Patwala K, Lau E, Goodwin M, Gow P.

Transplant Direct. 2018 Nov 23;4(12):e408. doi: 10.1097/TXD.0000000000000846. eCollection 2018 Dec.

14.

Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma.

Grigg S, Gow PJ, Yeomans N.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1330-1331. doi: 10.1111/apt.14963. No abstract available.

PMID:
30488624
15.

Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma.

Grigg S, Gow P, Yeomans N.

J Invest Surg. 2018 Nov 20:1-2. doi: 10.1080/08941939.2018.1513103. [Epub ahead of print] No abstract available.

PMID:
30457404
16.

Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.

Dalbeth N, Dowell T, Gerard C, Gow P, Jackson G, Shuker C, Te Karu L.

N Z Med J. 2018 Nov 9;131(1485):8-12. No abstract available.

PMID:
30408813
17.

Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.

Roberts SK, Gazzola A, Lubel J, Gow P, Bell S, Nicoll A, Dev A, Fink MA, Sood S, Knight V, Hong T, Paul E, Mishra G, Majeed A, Kemp W; Melbourne Liver Group.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1368-1375. doi: 10.1080/00365521.2018.1517277. Epub 2018 Nov 5.

PMID:
30394145
18.

Outcome of Acetaminophen-Induced Acute Liver Failure Managed Without Intracranial Pressure Monitoring or Transplantation.

Porteous J, Cioccari L, Ancona P, Osawa E, Jones K, Gow P, Angus P, Warrillow S, Bellomo R.

Liver Transpl. 2019 Jan;25(1):35-44. doi: 10.1002/lt.25377.

PMID:
30379388
19.

Dilated abdominal veins from Budd-Chiari syndrome and caval obstruction.

Apostolov R, Schelleman A, Gow P.

Lancet Gastroenterol Hepatol. 2018 Nov;3(11):812. doi: 10.1016/S2468-1253(18)30302-9. No abstract available.

PMID:
30353858
20.

Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.

Hong TP, Gow PJ, Fink M, Dev A, Roberts SK, Nicoll A, Lubel JS, Kronborg I, Arachchi N, Ryan M, Kemp WW, Knight V, Sundararajan V, Desmond P, Thompson AJ, Bell SJ.

Med J Aust. 2018 Oct 15;209(8):348-354.

PMID:
30309301
21.

Early viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation.

Sood S, Haifer C, Yu L, Pavlovic J, Gow PJ, Jones RM, Visvanathan K, Angus PW, Testro AG.

Transpl Infect Dis. 2018 Oct;20(5):e12934. doi: 10.1111/tid.12934. Epub 2018 Jun 19.

PMID:
29809312
22.

Leaky mode integrated optical fibre refractometer.

Gray AC, Jantzen A, Gow PC, Smith DH, Gawith CBE, Smith PGR, Holmes C.

Opt Express. 2018 Apr 2;26(7):9155-9164. doi: 10.1364/OE.26.009155.

PMID:
29715871
23.

Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.

Bloom S, Kemp W, Nicoll A, Roberts SK, Gow P, Dev A, Bell S, Sood S, Kronborg I, Knight V, Lewis D, Lubel J.

J Hepatol. 2018 Sep;69(3):575-583. doi: 10.1016/j.jhep.2018.04.013. Epub 2018 Apr 28.

PMID:
29709676
24.

Safety and effectiveness of umbilical hernia repair in patients with cirrhosis.

Hew S, Yu W, Robson S, Starkey G, Testro A, Fink M, Angus P, Gow P.

Hernia. 2018 Oct;22(5):759-765. doi: 10.1007/s10029-018-1761-9. Epub 2018 Mar 27.

PMID:
29589135
25.

Evanescent field refractometry in planar optical fiber.

Holmes C, Jantzen A, Gray AC, Gow PC, Carpenter LG, Bannerman RHS, Gates JC, Smith PGR.

Opt Lett. 2018 Feb 15;43(4):791-794. doi: 10.1364/OL.43.000791.

PMID:
29443995
26.

Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15).

McCaughan GW, Thwaites PA, Roberts SK, Strasser SI, Mitchell J, Morales B, Mason S, Gow P, Wigg A, Tallis C, Jeffrey G, George J, Thompson AJ, Parker FC, Angus PW; Australian Liver Association Clinical Research Network.

Aliment Pharmacol Ther. 2018 Feb;47(3):401-411. doi: 10.1111/apt.14404. Epub 2017 Dec 5.

27.

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.

Ong SY, Gurrin LC, Dolling L, Dixon J, Nicoll AJ, Wolthuizen M, Wood EM, Anderson GJ, Ramm GA, Allen KJ, Olynyk JK, Crawford D, Ramm LE, Gow P, Durrant S, Powell LW, Delatycki MB.

Lancet Haematol. 2017 Dec;4(12):e607-e614. doi: 10.1016/S2352-3026(17)30214-4.

PMID:
29195602
28.

Footwear interventions for foot pain, function, impairment and disability for people with foot and ankle arthritis: A literature review.

Frecklington M, Dalbeth N, McNair P, Gow P, Williams A, Carroll M, Rome K.

Semin Arthritis Rheum. 2018 Jun;47(6):814-824. doi: 10.1016/j.semarthrit.2017.10.017. Epub 2017 Nov 3. Review.

29.

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.

Roberts SK, Lim R, Strasser S, Nicoll A, Gazzola A, Mitchell J, Siow W, Khoo T, Hamarneh Z, Weltman M, Gow P, Janko N, Tse E, Mishra G, Cheng EH, Levy M, Cheng W, Sood S, Skoien R, Mitchell J, Zekry A, George J, MacQuillan G, Wigg A, Stuart K, Sievert W, McCaughan G; ALA Clinical Research Network.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):268-277. doi: 10.1016/j.cgh.2017.09.063. Epub 2017 Oct 16.

PMID:
29050991
30.

Terlipressin: Current and emerging indications in chronic liver disease.

Papaluca T, Gow P.

J Gastroenterol Hepatol. 2018 Mar;33(3):591-598. doi: 10.1111/jgh.14009. Review.

PMID:
28981166
31.

Observations from direct UV-written, non-hydrogen-loaded, thermally regenerated Bragg gratings in double-clad photosensitive fiber.

Jantzen A, Bannerman RHS, Berry SA, Gates JC, Gow PC, Boyd LJ, Smith PGR, Holmes C.

Opt Lett. 2017 Oct 1;42(19):3741-3744. doi: 10.1364/OL.42.003741.

PMID:
28957116
32.

Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.

Hey P, Lokan J, Johnson P, Gow P.

BMJ Case Rep. 2017 Sep 25;2017. pii: bcr-2017-221165. doi: 10.1136/bcr-2017-221165.

33.

Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort.

Otter SJ, Rohan M, Davies KA, Kumar S, Gow P, Dalbeth N, Corkill M, Panthakalam S, Rome K.

J Foot Ankle Res. 2017 Jul 26;10:33. doi: 10.1186/s13047-017-0217-2. eCollection 2017.

34.

The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.

Pardo F, Sangro B, Lee RC, Manas D, Jeyarajah R, Donckier V, Maleux G, Pinna AD, Bester L, Morris DL, Iannitti D, Chow PK, Stubbs R, Gow PJ, Masi G, Fisher KT, Lau WY, Kouladouros K, Katsanos G, Ercolani G, Rotellar F, Bilbao JI, Schoen M.

Ann Surg Oncol. 2017 Sep;24(9):2465-2473. doi: 10.1245/s10434-017-5950-z. Epub 2017 Jun 26.

PMID:
28653161
35.

Clinically-evident tophi are associated with reduced muscle force in the foot and ankle in people with gout: a cross-sectional study.

Stewart S, Dalbeth N, Otter S, Gow P, Kumar S, Rome K.

J Foot Ankle Res. 2017 Jun 19;10:25. doi: 10.1186/s13047-017-0207-4. eCollection 2017.

36.

Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipients.

Macesic N, Abbott IJ, Kaye M, Druce J, Glanville AR, Gow PJ, Hughes PD, Korman TM, Mulley WR, O'Connell PJ, Opdam H, Paraskeva M, Pitman MC, Setyapranata S, Rawlinson WD, Johnson PDR.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12739. Epub 2017 Jul 31.

PMID:
28618165
37.

Acute Life-Threatening Portal Hypertension After Portosystemic Shunt Embolization.

Khan SA, Pham C, Seah D, Ranatunga D, Gow PJ.

Am J Gastroenterol. 2017 May;112(5):816-818. doi: 10.1038/ajg.2017.62. No abstract available.

PMID:
28469231
38.

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, Bollipo S, Mitchell JL, Fragomeli V, Jones T, Chivers S, Gow P, Iser D, Levy M, Tse E, Gazzola A, Cheng W, Nazareth S, Galhenage S, Wade A, Weltman M, Wigg A, MacQuillan G, Sasadeusz J, George J, Zekry A, Roberts SK; Australian Liver Association Clinical Research Network (ALA CRN).

Antivir Ther. 2017;22(8):699-710. doi: 10.3851/IMP3168.

PMID:
28422043
39.

Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.

Mgaieth S, Kemp W, Gow P, Fink M, Lubel J, Nicoll A, Gazzola A, Hong T, Ryan M, Knight V, Dev AT, Sood S, Bell S, Paul E, Roberts SK.

J Viral Hepat. 2017 Nov;24(11):982-989. doi: 10.1111/jvh.12717. Epub 2017 Jun 9.

PMID:
28414893
40.

Foot involvement in systemic lupus erythematosus: more than joint disease?

Rome K, Dalbeth N, Jarrett P, Kumar S, Carroll M, Clendon A, Gow P.

Clin Exp Rheumatol. 2017 May-Jun;35(3):550. Epub 2017 Jan 27. No abstract available.

PMID:
28134089
41.

A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation.

Sood S, Haifer C, Yu L, Pavlovic J, Churilov L, Gow PJ, Jones RM, Angus PW, Visvanathan K, Testro AG.

Liver Transpl. 2017 Apr;23(4):487-497. doi: 10.1002/lt.24730.

42.

Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients.

Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG.

World J Hepatol. 2016 Dec 18;8(35):1569-1575. doi: 10.4254/wjh.v8.i35.1569.

43.

Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography.

Lloyd-Donald P, Vasudevan A, Angus P, Gow P, Mårtensson J, Glassford N, Eastwood GM, Hart GK, Bellomo R.

J Crit Care. 2017 Apr;38:215-224. doi: 10.1016/j.jcrc.2016.10.030. Epub 2016 Nov 4.

PMID:
27978499
44.

Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score.

Sinclair M, Gow PJ, Grossmann M, Shannon A, Hoermann R, Angus PW.

Liver Transpl. 2016 Nov;22(11):1482-1490. doi: 10.1002/lt.24607.

45.

Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.

Sinclair M, Grossmann M, Hoermann R, Angus PW, Gow PJ.

J Hepatol. 2016 Nov;65(5):906-913. doi: 10.1016/j.jhep.2016.06.007. Epub 2016 Jun 14.

PMID:
27312945
46.
47.

A qualitative study to explore health professionals' experience of treating gout: understanding perceived barriers to effective gout management.

Humphrey C, Hulme R, Dalbeth N, Gow P, Arroll B, Lindsay K.

J Prim Health Care. 2016 Jun;8(2):149-56. doi: 10.1071/HC15017.

PMID:
27477557
48.

Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.

Gow PJ, Ardalan ZS, Vasudevan A, Testro AG, Ye B, Angus PW.

Am J Gastroenterol. 2016 Jul;111(7):1041-2. doi: 10.1038/ajg.2016.168. No abstract available.

PMID:
27356836
49.

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study.

Doyle A, Marsh P, Gill R, Rodov M, Mohsen W, Varma P, Hong T, Strasser SI, Bell S, Ryan M, Nicoll A, Lubel J, Gow PJ, Fink MA, Roberts S, Kemp W, Kronborg I, Arachchi N, Knight V, Dev A.

Scand J Gastroenterol. 2016 Aug;51(8):979-85. doi: 10.3109/00365521.2016.1166518. Epub 2016 May 10.

PMID:
27161568
50.

Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey.

Otter SJ, Kumar S, Gow P, Dalbeth N, Corkill M, Rohan M, Davies KA, Pankathelam S, Rome K.

J Foot Ankle Res. 2016 Mar 22;9:10. doi: 10.1186/s13047-016-0143-8. eCollection 2016.

Supplemental Content

Support Center